Amendment119th Congress
5336
- Amendment Number
- 5336
- Purpose
- To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
- Congress
- 119
- Type
- SAMDT
- Latest Action Date
- Apr 23, 2026
- Latest Action Text
- Amendment SA 5336 not agreed to in Senate by Yea-Nay Vote. 48 - 50. Record Vote Number: 103.
- Proposed Date
- Apr 23, 2026
- Submitted Date
- Apr 22, 2026
- Chamber
- Senate
- Update Date
- Apr 23, 2026